Gender-related issues in the female inflammatory bowel disease patient

References

• Trachter AB, Rogers AI, Leiblum SR. Inflammatory bowel disease in women: impact on relationship and sexual health. Inflamm. Bowel Dis.8(6), 413–421 (2002).
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Rifas-Shiman SL, Klkeinman K et al. The prevelance and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin. Gastroenterol. Hepatol.5, 1424–1429 (2007).
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn’s disease. Am. J. Gastroenterol.84, 31–33 (1989).
   PubMed Web of Science ®Google Scholar
• Maunder R, Toner B, de Rooy E, Moskovitz D. Influence of sex and disease on illness-related concerns in inflammatory bowel disease. Can. J. Gastroenterol.13(9), 728–732 (1999).
   PubMedGoogle Scholar
• Counihan TC, Roberts PL, Schoetz DJ Jr, Coller JA, Murray JJ, Veidenheimer MC. Fertility and sexual and gynecologic function after ileal pouch–anal anastomosis. Dis. Colon Rectum37, 1126–1129 (1994).
   PubMed Web of Science ®Google Scholar
• Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am. J. Gastroenterol.93, 1867–1872 (1998).
   PubMed Web of Science ®Google Scholar
• Timonen S, Procrope B. The premenstrual syndrome: frequency and association of symptoms. Ann. Chir. Gyn. Fenn.62, 108–116 (1973).
   PubMedGoogle Scholar
• Rees WD, Rhodes J. Altered bowel habit and menstruation. Lancet1(7982), 475 (1976).
   Google Scholar
• Weber AM, Ziegler C, Belinson JL et al. Gynecologic history of women with inflammatory bowel disease. Obstet. Gyncol.86, 843–847 (1995).
   PubMedGoogle Scholar
• Jaffe B. Prostaglandins and serotonin in diarrheogenic syndromes. In: Gastrointestinal Hormones and the Pathology of the Digestive System. Grossman M (Ed.). Plenum Press, NY, USA (1978).
   Google Scholar
• Erkan P, Ulku D, Canan A et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk. J. Gastroenterol.14(4), 250–256 (2003).
   PubMedGoogle Scholar
• Lichtarowicz A, Norman C, Calcraft B et al. A study of the menopause, smoking, and contraception in women with Crohn’s disease. Q. J. Med.72, 623–631 (1989).
   PubMedGoogle Scholar
• Bernard VB, Eheman CR, Lawson HW et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program 1995–2001. Obstet. Gynecol.103, 564–571 (2004).
   PubMedGoogle Scholar
• Edelman M, Fox AS, Alderman EM et al. Cervical Papanicolau smear abnormalities in inner city Bronx adolescents: prevalence, progression, and immune modifiers. Cancer87, 184–189 (1999).
   PubMedGoogle Scholar
• Tam LS, Chan AY, Chan PK et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum.50, 3619–3625 (2004).
   PubMed Web of Science ®Google Scholar
• Bhatia J, Bratcher J, Korelitz B et al. Abnormalities of uterine cervix in women with inflammatory bowel disease. World J. Gastroenterol.12(38), 6167–6171 (2006).
   PubMed Web of Science ®Google Scholar
• Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am. J. Gastroenterol.103, 631–636 (2008).
   PubMed Web of Science ®Google Scholar
• Hutfless S, Fireman B, Kane S et al. Screening differences and risks of cervical cancer in inflammatory bowel disease. Aliment. Pharmacol. Ther.28, 598–605 (2008).
   PubMed Web of Science ®Google Scholar
• Lees C, Critchley J, Chee N et al. Cervical dysplasia and inflammatory bowel disease: no effect of disease status or immunosuppressants on analysis of 2,199 smear records. Gastroenterology134(4 Suppl. 1), A967 (2008).
   Google Scholar
• Singh H, Demers A, Nugent A et al. Risk of cervical abnormalities in women with IBD: a population-based nested case–control study. Gastroenterology134(4 Suppl. 1), A965 (2008).
   Google Scholar
• Lyles T, Oster R, Gutierrez A. Prevalence of abnormal pap smears in patients with inflammatory bowel disease on immune modulator therapy. Gastroenterology134(4 Suppl. 1), A966 (2008).
   Google Scholar
• Miller JP. Inflammatory bowel disease in pregnancy: a review. J. R. Soc. Med.79, 221–225 (1986).
   PubMed Web of Science ®Google Scholar
• Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn’s disease: a case–control study by European collaborative group. Gut27, 821–825 (1986).
   PubMed Web of Science ®Google Scholar
• Fonager K, Sorensen HT, Olsen J et al. Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am. J. Gastroenterol.93, 2426–2430 (1998).
   PubMed Web of Science ®Google Scholar
• Alstead E. Fertility and pregnancy in inflammatory bowel disease. World J. Gastroenterol.7(4), 455–459 (2001).
   PubMedGoogle Scholar
• Waljee A, Waljee J, Morris A, Higgin PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut55, 1575–1580 (2006).
   PubMed Web of Science ®Google Scholar
• Mortier PE, Gambiez L, Karoui M et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol. Clin. Biol.30, 594–597 (2006).
   PubMedGoogle Scholar
• O’Morian C, Smethurst P, Dore CJ et al. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut25, 1078–1084 (1984).
   PubMedGoogle Scholar
• Burnell D, Mayberry J, Calcraft BJ et al. Male fertility in Crohn’s disease. Postgrad. Med. J.62, 269–272 (1986).
   PubMedGoogle Scholar
• Mahadeven U, Terdiman JP, Aron J et al. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm. Bowel Dis.11(4), 359–359 (2005).
   Google Scholar
• Orholm M, Fonager K, and Sorensen HT. Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am. J. Gastroenterol.94, 3236–3238 (1999).
   PubMedGoogle Scholar
• Yang H, McElree C, Roth MP et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut34, 517–524 (1993).
   PubMed Web of Science ®Google Scholar
• Hanker JP. Gastrointestinal disease and oral contraception. Am. J. Obstet. Gynecol.163, 2204–2207 (1990).
   PubMed Web of Science ®Google Scholar
• Cosnes J, Carbonnel F, Carrat F et al. Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study. Gut45, 218–222 (1999).
   PubMed Web of Science ®Google Scholar
• Cornish J, Emile T, Simillis C et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am. J. Gastroenterol.103, 2394–2400 (2008).
   PubMed Web of Science ®Google Scholar
• Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology114, 1143–1150 (1998).
   PubMed Web of Science ®Google Scholar
• Wright JP. Factors influencing first relapse in patients with Crohn’s disease. J. Clin. Gastroenterol.15, 12–16 (1992).
   PubMedGoogle Scholar
• Sutherland LR, Ramcharan S, Bryant H et al. Effect of oral contraceptive use on reoperation following surgery for Crohn’s disease. Dig. Dis. Sci.37, 1377–1382 (1992).
   PubMedGoogle Scholar
• Cornish J, Tan E, Teoh T et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut56, 830–837 (2007).
   PubMed Web of Science ®Google Scholar
• Moser MA, Okun NB, Mayes DC et al. Crohn’s disease, pregnancy, and birth weight. Am. J. Gastroenterol.95, 1021–1026 (2000).
   PubMedGoogle Scholar
• Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case–controlled retrospective analysis. Br. J. Obstet. Gynaecol.93, 1124–1131 (1986).
   PubMedGoogle Scholar
• Ilnyckyj A, Blanchard JF, Rawsthorne P et al. Perianal Crohn’s disease and pregnancy: role of the mode of delivery. Am. J. Gastroenterol.94, 3274–3278 (1999).
   PubMed Web of Science ®Google Scholar
• Riis L, Vind I, Politi P et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am. J. Gastroenterol.101, 1539–1545 (2006).
   PubMed Web of Science ®Google Scholar
• Castiglione F, Pignata S, Morace F et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital. J. Gastroenterol.28, 199–204 (1996).
   PubMedGoogle Scholar
• Nwokolo C, Tan WC, Andrews HA et al. Surgical resections in parous patients with distal ileal and colonic Crohn’s disease. Gut35, 220–223 (1994).
   PubMedGoogle Scholar
• Cappell MS, Colon VJ, Sidhom OA. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig. Dis. Sci.41, 2353–2361 (1996).
   PubMed Web of Science ®Google Scholar
• Sachar D. Exposure to mesalamine during pregnancy increased preterm deliveries (but not birth defects) and decreased birth weight. Gut43, 316 (1998).
   PubMedGoogle Scholar
• Mahadevan U, Sandborn WJ, Li DK et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from northern California. Gastroenterology133, 1106–1112 (2007).
   PubMed Web of Science ®Google Scholar
• Diav-Citrin O, Park YH, Veerasuntharam G. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology114, 23–28 (1998).
   PubMed Web of Science ®Google Scholar
• Marteau P, Tennenbaum R, Elefant E. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment. Pharmacol. Ther.12, 1101–1108 (1998).
   PubMed Web of Science ®Google Scholar
• McKay DB, Josephson AM. Pregnancy in recipients of solid organs – effects on mother and child. N. Engl. J. Med.354(12), 1281–1293 (2006).
   PubMed Web of Science ®Google Scholar
• Francella A, Dayan A, Bodian C et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology124(1), 9–17 (2003).
   PubMed Web of Science ®Google Scholar
• De Boer NK, Jarbandhan SV, Peer de Graff MS et al. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am. J. Gastroenterol.101, 1390–1392 (2006).
   PubMed Web of Science ®Google Scholar
• Norgard B, Pedersen L, Christensen LA, Sorensen HT. Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am. J. Gastroenterol.102, 1406–1413 (2007).
   PubMed Web of Science ®Google Scholar
• Langagergaard V, Pedersen L, Gisium M et al. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment. Pharmacol. Ther.25, 73–81 (2007).
   PubMed Web of Science ®Google Scholar
• Mahadevan U, Kane S, Sandborn WJ et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn’s disease. Aliment. Pharmacol. Ther.21(6), 733–738 (2005).
   PubMed Web of Science ®Google Scholar
• Vasiliauskas EA, Chruch JA, Silverman N et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin. Gastroenterol. Hepatol.4, 1255–1258 (2006).
   PubMed Web of Science ®Google Scholar
• Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut54(6), 890 (2005).
   PubMed Web of Science ®Google Scholar
• Mishkin D, van Deinse W, Becker J, Farraye FA. Successful use of adalimumab for Crohn’s disease in pregnancy. Inflamm. Bowel Dis.12(8), 827–828 (2006).
   PubMed Web of Science ®Google Scholar
• Mahadevan U, Nazareth M, Cristiano L et al. Natalizumab use during pregnancy. Am. J. Gastroenterol.103(4 Suppl. 1), A1150 (2008).
   Google Scholar
• Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet. Gynecol.69, 751–755 (1987).
   PubMed Web of Science ®Google Scholar
• Lepisto A, Sarna S, Tiitinen A, Jarvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br. J. Surg.94, 478–482 (2007).
   PubMed Web of Science ®Google Scholar
• Cornish J, Tan E, Teare J et al. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy, and delivery: a systematic review. Dis. Colon Rectum50, 1128–1138 (2007).
   PubMed Web of Science ®Google Scholar
• Tiainen J, Matikainen M, Hiltunen KM. Ileal J-pouch – anal anastomosis, sexual dysfunction, and fertility. Scand. J. Gastroenterol.34, 185–188 (1999).
   PubMed Web of Science ®Google Scholar
• Damgaard B, Wettergren A, Kirkegaard P. Social and sexual function following ileal pouch-anal anastomosis. Dis. Colon Rectum38, 286–289 (1995).
   PubMed Web of Science ®Google Scholar
• Bambrick M, Fazio VW, Hull TL, Pucel G. Sexual function following restorative proctocolectomy in women. Dis. Colon Rectum39, 610–614 (1996).
   PubMed Web of Science ®Google Scholar
• Metcalf AM, Dozois RR, Kelly KA. Sexual function in women after proctocolectomy. Ann. Surg.204(6), 624–628 (1986).
   PubMed Web of Science ®Google Scholar
• Kane S, Reddy D. Hormone replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am. J. Gastroenterol.103, 1193–1196 (2008).
   PubMed Web of Science ®Google Scholar